✦ LIBER ✦

A randomized phase II trial of low-dose aclarubicin vs very low-dose cytosine arabinoside for treatment of myelodysplastic syndromes

✍ Scribed by Mine Harada; Tsunefumi Shibuya; Takanori Teshima; Masahiro Murakawa; Takashi Okamura; Yoshiyuki Niho; Hisashi Gondo; Shin Hayashi; Koichi Akashi; Kazuo Tamura; Shigeyoshi Makino; Hideyo Natori; Koichiro Egami; Shusuke Hisano; Eiji Morioka; Shuichi Taniguchi; Kazuo Yamazaki; Yujiro Yamano; Fusayuki Omori

Book ID: 113239751
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 277 KB
Volume: 17
Category: Article
ISSN: 0145-2126
DOI: 10.1016/0145-2126(93)90066-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase-II trial of alltransretinoic aci

A phase-II trial of alltransretinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes

✍ A. Venditti; A. Tamburini; F. Buccisano; M. T. Scimò; G. Del Poeta; L. Maurillo; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 78 KB

Low-dose-rate Brachytherapy for the Trea

Low-dose-rate Brachytherapy for the Treatment of Postprostatectomy Local Recurrence: A Phase II Trial

✍ Gomez-Veiga, F.; Mariño, A.; Castelo, L.; Candal, A.; Pertega, S.; Fernadez, C.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Aclarubicin and Low-Dose Cytosine Arabin

Aclarubicin and Low-Dose Cytosine Arabinoside in Combination with Granulocyte Colony-Stimulating Factor in Treating Acute Myeloid Leukemia Patients with Relapsed or Refractory Disease and Myelodysplastic Syndrome: A Multicenter Study of 112 Chinese Patients

✍ J. M. Li; Y. Shen; D. P. Wu; H. Liang; J. Jin; F. Y. Chen; Y. P. Song; J. M. Wan 📂 Article 📅 2005 🏛 Carden Jennings Publishing 🌐 English ⚖ 114 KB

High vs. low doses of low-molecular-weig

High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial

✍ THE VESALIO INVESTIGATORS GROUP 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Combined low-dose flutamide plus finaste

Combined low-dose flutamide plus finasteride vs low-dose flutamide monotherapy for recurrent prostate cancer: a comparative analysis of two phase II trials with a long-term follow-up

✍ Lionel L. Bañez; Gary W. Blake; David G. McLeod; E. David Crawford; Judd W. Moul 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

A non-randomised dose-escalating phase I

A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Français des Myélodysplasies

✍ Didier Bouscary; Laurence Legros; Micheline Tulliez; Stéphanie Dubois; Béatrice 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB